Patent ID: 11890348
Assignee: THE GENERAL HOSPITAL CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. A composition consisting of an anti-fugetactic agent complexed to an antibody, wherein the anti-fugetactic agent is selected from the group consisting of AMD3100, KRH-1636, T-20, T-22, T-140, TE-14011, T-14012, TN14003, TAK-779, AK602, SCH-351125, NSC 651016, GF 109230X, tannic acid, and thalidomide, and wherein the antibody is specific for a tumor antigen selected from the group consisting of EpCAM, CK20, CK30, CD33, CD47, CD52, CD133, CEA gpA33, mucins, TAG-72, CIXPSMA, folate binding protein, GD2 GD3, GM2, VEGH, VEGFR, integrin aV3, integrin a5, and ERBB2.